SKU(재고 관리 코드):LMA362Hu
Magnetic Luminex Assay Kit for Urotensin 2 (UST2) ,etc.
Magnetic Luminex Assay Kit for Urotensin 2 (UST2) ,etc.
Product No.
LMA362Hu
Organism Species
Homo sapiens (Human).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Competitive Inhibition
Assay Length
1.5h
Detection Range
0.98-1000pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.327 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Urotensin 2 (UST2) ,etc..
No significant cross-reactivity or interference between Urotensin 2 (UST2) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Urotensin 2 (UST2) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Urotensin 2 (UST2) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 88-102 | 98 |
EDTA plasma(n=5) | 83-95 | 89 |
heparin plasma(n=5) | 92-101 | 97 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Urotensin 2 (UST2) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Urotensin 2 (UST2) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Urotensin 2 (UST2) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 81-96% | 78-97% | 80-95% | 98-105% |
EDTA plasma(n=5) | 83-97% | 84-98% | 95-103% | 89-103% |
heparin plasma(n=5) | 85-97% | 83-97% | 78-91% | 87-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:UST2) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 50μL standard or sample to each well,
add 10μL magnetic beads,and 50μL Detection Reagent A,incubate 60min at 37°C on shaker;
3. Wash plate on magnetic frame for three times;
4. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
5. Wash plate on magnetic frame for three times;
6. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Clinical and Experimental Hypertension | Serum Urotensin II Levels in Patients with Non-Dipper Hypertension Pubmed: 23301552 |
Peptides | Urotensin II (U-II), a novel cyclic peptide, possibly associated with the pathophysiology of osteoarthritis Pubmed: 24468547 |
journal of diabetes and its complications | Urotensin-II level and its association with oxidative stress in early diabetic nephropathy. pubmed:25179234 |
Evidence-based Complementary and Alternative Medicine | Acute Biochemical, Cardiovascular, and Autonomic Response to Hyperbaric (4 atm) Exposure in Healthy Subjects Pubmed:29977313 |
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | The Relationship of the Urotensin-2 Level in the Aqueous Humor with Systemic Diseases and Pupil Size: Comparative Study Pubmed: 33147089 |
Boy kısalığı olan çocukların serum ürotensin 2 düzeylerinin igf-1 ile ilişkisi. |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA362Hu01 | Recombinant Urotensin 2 (UST2) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA362Hu21 | OVA Conjugated Urotensin 2 (UST2) | Immunogen; SDS-PAGE; WB. |
CPA362Hu31 | KLH Conjugated Urotensin 2 (UST2) | Immunogen; SDS-PAGE; WB. |
PAA362Hu01 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
PAA362Hu08 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
LAA362Hu71 | Biotin-Linked Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC. |
MAA362Hu22 | Monoclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
CEA362Hu | ELISA Kit for Urotensin 2 (UST2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA362Hu | Magnetic Luminex Assay Kit for Urotensin 2 (UST2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |